The team has published their findings in a paper titled "Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPKi-resistant NRAS MUT melanoma" in the journal ...

Melanoma is a type of skin cancer. When it spreads to other places in your body, it's called metastatic, or advanced. If you have fair skin or you’ve spent lots of time in the sun, it’s a ...

In December 2024, the FDA awarded fast-track designation to IMM-1-104 for treating patients with unresectable or metastatic NRAS-mutant melanoma who have either progressed on or cannot tolerate PD ...